The year 2020 will be a tumultuous one, within health care and everywhere else. We’re a deeply divided nation, and the upcoming elections mean that things will likely get more difficult before they get easier. How the election affects pharmacy is still a major question mark — we get mixed signals across both sides of
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. Today, pharmacists are facing a health care environment that presents both opportunities and challenges. On one hand, there are opportunities as the health care system shifts to value-based payment and other health care providers increasingly recognize that utilization of pharmacists
WASHINGTON — A group of senators are sponsoring legislation to bring more prescription drug pricing transparency to the pharmacy counter. Sens. Susan Collins (R., Maine), Claire McCaskill (D., Mo.) and Debbie Stabenow (D., Mich.) yesterday introduced the Patient Right to Know Drug Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), which would
Rep. Tom Price (R., Ga.) had a tense confirmation hearing in the Senate last week for his nomination by President Donald Trump as secretary of the Department of Health and Human Services (HHS). But he got a thumbs-up from the American Pharmacists Association (APhA) on at least one count: pharmacists’ place in the U.S. health
WASHINGTON — The Alliance for Safe Online Pharmacies (ASOP Global) has partnered with the American Medical Association (AMA), American Pharmacists Association (APhA) and 14 other national health care stakeholders to educate providers and patients about the surge in illegal online pharmacies and counterfeit medicines. To that end, ASOP Global also launched BuySafeRx.pharmacy, a website providers,
